Predictive factors for tuberculous peripheral pulmonary lesions during radial endobronchial ultrasound

IF 3.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
{"title":"Predictive factors for tuberculous peripheral pulmonary lesions during radial endobronchial ultrasound","authors":"","doi":"10.1016/j.rmed.2024.107805","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Tuberculosis frequently poses diagnostic challenge when it presents as a peripheral pulmonary lesion (TB-PPL). The growing use of radial endobronchial ultrasound (rEBUS) for PPL biopsy highlights the need to identify predictive factors for TB-PPL, which is crucial for procedure safety.</p></div><div><h3>Methods</h3><p>A six-year retrospective review at our institution on adult patients with TB and malignant-PPL diagnosed from rEBUS procedure from October 1, 2016, to December 31, 2022. Clinical, radiological, procedural, histological and microbiological data were extracted and analysed.</p></div><div><h3>Results</h3><p>387 PPLs were included in our cohort, 32 % were TB-PPL and 68 % were malignant-PPL. The median age was 63 (IQR 55–70) years, with the TB-PPL group significantly younger. The median size of the target lesion was 2.90 (IQR 2.26–4.00) cm. The overall rEBUS diagnostic yield was 85.3 %, with a 1.3 % pneumothorax risk. Multivariate analysis identified independent predictors for TB-PPL, including age &lt;60 years (<em>adj OR 2.635</em>), target lesion size &lt;2 cm (<em>adj OR 2.385</em>), upper lobe location (<em>adj OR 2.020</em>), presence of a cavity on pre-procedural CT (<em>adj OR 4.186</em>), and presence of rEBUS bronchogram (<em>adj OR 2.722</em>). These variables achieved an area under the curve of 0.729 (95 % CI 0.673–0.795) with a diagnostic accuracy of 75.49 % (95 % CI 70.68–79.88).</p></div><div><h3>Conclusions</h3><p>Despite non-specific radiological findings in TB-PPL, our study identifies younger age, target lesion size less than 2 cm, upper lobe location, the presence of cavitation, and rEBUS bronchogram were independent clinical predictors for TB-PPL. This prediction model potentially helps mitigate the risk of accidental TB exposure during bronchoscopic procedures. A future prospective cohort study to validate these findings is essential to allow proper triaging of patient planning for rEBUS procedure.</p></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611124002804","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Tuberculosis frequently poses diagnostic challenge when it presents as a peripheral pulmonary lesion (TB-PPL). The growing use of radial endobronchial ultrasound (rEBUS) for PPL biopsy highlights the need to identify predictive factors for TB-PPL, which is crucial for procedure safety.

Methods

A six-year retrospective review at our institution on adult patients with TB and malignant-PPL diagnosed from rEBUS procedure from October 1, 2016, to December 31, 2022. Clinical, radiological, procedural, histological and microbiological data were extracted and analysed.

Results

387 PPLs were included in our cohort, 32 % were TB-PPL and 68 % were malignant-PPL. The median age was 63 (IQR 55–70) years, with the TB-PPL group significantly younger. The median size of the target lesion was 2.90 (IQR 2.26–4.00) cm. The overall rEBUS diagnostic yield was 85.3 %, with a 1.3 % pneumothorax risk. Multivariate analysis identified independent predictors for TB-PPL, including age <60 years (adj OR 2.635), target lesion size <2 cm (adj OR 2.385), upper lobe location (adj OR 2.020), presence of a cavity on pre-procedural CT (adj OR 4.186), and presence of rEBUS bronchogram (adj OR 2.722). These variables achieved an area under the curve of 0.729 (95 % CI 0.673–0.795) with a diagnostic accuracy of 75.49 % (95 % CI 70.68–79.88).

Conclusions

Despite non-specific radiological findings in TB-PPL, our study identifies younger age, target lesion size less than 2 cm, upper lobe location, the presence of cavitation, and rEBUS bronchogram were independent clinical predictors for TB-PPL. This prediction model potentially helps mitigate the risk of accidental TB exposure during bronchoscopic procedures. A future prospective cohort study to validate these findings is essential to allow proper triaging of patient planning for rEBUS procedure.

Abstract Image

径向支气管内超声检查肺结核周围病变的预测因素
背景肺结核以肺部周围病变(TB-PPL)的形式出现时,常常会给诊断带来挑战。随着径向支气管内超声(rEBUS)在肺外周病变活检中的应用日益广泛,确定肺结核肺外周病变的预测因素显得尤为重要,这对手术安全至关重要。我们提取并分析了临床、放射学、手术、组织学和微生物学数据。中位年龄为 63(IQR 55-70)岁,TB-PPL 组明显更年轻。靶病灶的中位尺寸为 2.90(IQR 2.26-4.00)厘米。总体 rEBUS 诊断率为 85.3%,气胸风险为 1.3%。多变量分析确定了 TB-PPL 的独立预测因素,包括年龄 <60 岁(adj OR 2.635)、靶病灶大小 <2 厘米(adj OR 2.385)、上叶位置(adj OR 2.020)、术前 CT 存在空洞(adj OR 4.186)和存在 rEBUS 支气管造影(adj OR 2.722)。这些变量的曲线下面积为 0.729 (95 % CI 0.673-0.795),诊断准确率为 75.49 % (95 % CI 70.68-79.88)。结论尽管 TB-PPL 有非特异性的放射学发现,但我们的研究发现年龄较小、靶病灶大小小于 2 厘米、上叶位置、存在空洞和 rEBUS 支气管造影是 TB-PPL 的独立临床预测因素。这一预测模型可能有助于降低支气管镜手术中意外暴露结核病的风险。未来的前瞻性队列研究必须验证这些发现,以便对计划接受 rEBUS 手术的患者进行适当分流。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respiratory medicine
Respiratory medicine 医学-呼吸系统
CiteScore
7.50
自引率
0.00%
发文量
199
审稿时长
38 days
期刊介绍: Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants. Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信